Navigation Links
Kendle to Present at Robert W. Baird & Co. 2010 Health Care Conference
Date:9/8/2010

CINCINNATI, Sept. 8 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming Robert W. Baird & Co. 2010 Health Care Conference on Sept. 14, 2010 at the St. Regis New York in New York City.

Kendle's formal presentation will be given by Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer and Keith Cheesman, Senior Vice President and Chief Financial Officer at 1:45 p.m. Eastern Time.

The presentation will be webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://www.wsw.com/webcast/baird16/kndl.    

Slides will be available by 11 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section. The webcast will be archived for 90 days following the live presentation.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's website at www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Appoints Jeffrey M. Zucker to Lead Global Patient Recruitment Efforts
2. Kendle Rated a Top CRO to Work with for Fourth Consecutive Year
3. Kendle Announces New Revolving Credit Facility
4. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2009 Earnings Conference Call and Webcast
5. Kendle to Present at UBS Global Life Sciences Conference
6. Kendle to Present at Robert Baird 2009 Health Care Conference
7. Kendle Realigns C-Suite Leadership to Drive Increased Innovation, Productivity and Organizational Efficiency
8. Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
9. Kendle Names Jarrod Pontius Chief Legal Officer
10. Kendle Expands Asia/Pacific Operations with Opening of Offices in Kuala Lumpur, Bangkok and Manila
11. Kendle Announces First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 2016 , ... Curoverse announced today that the open-source, multi-platform ... for managing and processing genomic and health data at petabyte scale. ... analyzing genomic data,” said Adam Berrey chief executive officer at Curoverse. “Microsoft Azure ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused ... announced today it has been selected to present at the Cavendish Global Health Impact ... Florida. The purpose of the Forum is to help family offices and foundations ...
(Date:2/9/2016)... ... February 09, 2016 , ... With a presidential election in ... Care Business Conference will bring together over 500 top healthcare leaders for a night ... transformation. The conference, organized by MBA students of the University of Pennsylvania’s Wharton School, ...
(Date:2/9/2016)... ... February 08, 2016 , ... Date and time: March ... at the Pennsylvania Biotechnology Center of Bucks County, 3805 Old Easton Road, Doylestown, ... (TCMC) will hold an open house for participants to learn about a new ...
Breaking Biology Technology:
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/2/2016)... 2, 2016   Parabon NanoLabs (Parabon) ... Army Research Office and the Defense Forensics and ... of the company,s Snapshot Kinship Inference ... more generally, defense-related DNA forensics.  Although Snapshot is ... appearance and ancestry from DNA evidence), it also ...
Breaking Biology News(10 mins):